Xuanzhu Biopharmaceutical Statistics

Total Valuation

HKG:2575 has a market cap or net worth of HKD 36.52 billion. The enterprise value is 36.40 billion.

Market Cap	36.52B
Enterprise Value	36.40B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

HKG:2575 has 517.95 million shares outstanding. The number of shares has increased by 14.22% in one year.

Current Share Class	160.70M
Shares Outstanding	517.95M
Shares Change (YoY)	+14.22%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.82%
Owned by Institutions (%)	5.93%
Float	74.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,042.76
PB Ratio	39.40
P/TBV Ratio	42.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-59.70
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-168.49

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.00.

Current Ratio	1.43
Quick Ratio	0.78
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-1,636.34

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-63.04%
Revenue Per Employee	177,756
Profits Per Employee	-3.09M
Employee Count	396
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, HKG:2575 has paid 6,575 in taxes.

Income Tax	6,575
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	65.31
200-Day Moving Average	n/a
Relative Strength Index (RSI)	57.97
Average Volume (20 Days)	380,240

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2575 had revenue of HKD 35.02 million and -609.65 million in losses. Loss per share was -1.35.

Revenue	35.02M
Gross Profit	14.86M
Operating Income	-622.19M
Pretax Income	-609.64M
Net Income	-609.65M
EBITDA	-597.06M
EBIT	-622.19M
Loss Per Share	-1.35

Full Income Statement

Balance Sheet

The company has 120.30 million in cash and 1.17 million in debt, giving a net cash position of 119.13 million or 0.23 per share.

Cash & Cash Equivalents	120.30M
Total Debt	1.17M
Net Cash	119.13M
Net Cash Per Share	0.23
Equity (Book Value)	926.82M
Book Value Per Share	2.06
Working Capital	77.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -215.83 million and capital expenditures -189,570, giving a free cash flow of -216.02 million.

Operating Cash Flow	-215.83M
Capital Expenditures	-189,570
Free Cash Flow	-216.02M
FCF Per Share	-0.42

Full Cash Flow Statement

Margins

Gross Margin	42.43%
Operating Margin	-1,776.79%
Pretax Margin	-1,740.95%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:2575 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.22%
Shareholder Yield	-14.22%
Earnings Yield	-1.67%
FCF Yield	-0.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2575 has an Altman Z-Score of -4.53 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.53
Piotroski F-Score	1